| Application no. and date | 06771163.0 (espacenet) (Federated) (European Patent Register), 20060525 | | Patent/reg. no. and date | DK/EP 1913001, 20130904 | | Publication date | 20080423 | | Priority no. and date | US 684616 P, 20050525 | | EP pub. no. and date |
EP 1913001 20080423 | | Effective date | | | Applicant/owner | PROGENICS PHARMACEUTICALS, INC., 331 Treble Cove Road
North Billerica, MA 01862, US | | Applicant ref. no. | 01785-EP-DK | | Inventor | DOSHAN, Harold, D., 18 Griffith Road
Riverside, CT 06878, US,
PEREZ, Julio, 273D South Broadway
Tarrytown, NY 01591, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/485 (2006.01) , A61P 1/10 (2006.01) , A61P 25/04 (2006.01) , C07D 489/08 (2006.01) | | Title | (R)-N-METHYLNALTREXON, FREMGANGSMÅDER TIL SYNTESE OG FARMACEUTISK ANVENDELSE HERAF | | Int. application no. | US2006020233 | | Int. publication no. | WO2006127899 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
